New York Clinical Trials-Brooklyn is a clinical research site located in Brooklyn, New York, United States.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
New York Clinical Trials-Brooklyn has participated in 1 clinical trials.
Therapeutic areas: Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations.
Sponsors: Rhythm Pharmaceuticals, Inc..
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
New York Clinical Trials-Brooklyn has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York Clinical Trials-Brooklyn has 1 clinical trials on record. Their work covers Pro-opiomelanocortin (POMC), Proprotein Convertase Subtilisin/Kexin Type 1 (PCSK1) and Leptin Receptor (LepR) Gene Mutations.
New York Clinical Trials-Brooklyn has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.